SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Ehrich Elliot

(Last) (First) (Middle)
852 WINTER ST.

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, R&D & CMO, Alkermes, Inc.
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2011
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/16/2011 A 18,579 A (1) 18,579 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (Right to Buy) $19.4 09/16/2011 A 5,157 (2) 10/02/2011 Common Stock 5,157 (3) 5,157 D
Non Qualified Stock Option (Right to Buy) $19.4 09/16/2011 A 69,843 (2) 10/02/2011 Common Stock 69,843 (3) 69,843 D
Non Qualified Stock Option (Right to Buy) $14.57 09/16/2011 A 25,269 (2) 10/17/2013 Common Stock 25,269 (3) 25,269 D
Incentive Stock Option (Right to Buy) $14.57 09/16/2011 A 1,731 (2) 10/17/2013 Common Stock 1,731 (3) 1,731 D
Non Qualified Stock Option (Right to Buy) $12.16 09/16/2011 A 44,500 (2) 12/10/2013 Common Stock 44,500 (3) 44,500 D
Non Qualified Stock Option (Right to Buy) $12.3 09/16/2011 A 22,500 (2) 07/12/2014 Common Stock 22,500 (3) 22,500 D
Incentive Stock Option (Right to Buy) $12.3 09/16/2011 A 7,500 (2) 07/12/2014 Common Stock 7,500 (3) 7,500 D
Incentive Stock Option (Right to Buy) $14.9 09/16/2011 A 520 (2) 12/17/2014 Common Stock 520 (3) 520 D
Non Qualified Stock Option (Right to Buy) $14.9 09/16/2011 A 70,980 (2) 12/17/2014 Common Stock 70,980 (3) 70,980 D
Incentive Stock Option (Right to Buy) $18.6 09/16/2011 A 5,376 (2) 12/09/2015 Common Stock 5,376 (3) 5,376 D
Non Qualified Stock Option (Right to Buy) $18.6 09/16/2011 A 32,624 (2) 12/09/2015 Common Stock 32,624 (3) 32,624 D
Incentive Stock Option (Right to Buy) $20.79 09/16/2011 A 4,687 (2) 05/02/2016 Common Stock 4,687 (3) 4,687 D
Non Qualified Stock Option (Right to Buy) $20.79 09/16/2011 A 14,063 (2) 05/02/2016 Common Stock 14,063 (3) 14,063 D
Non Qualified Stock Option (Right to Buy) $14.38 09/16/2011 A 20,323 (2) 12/12/2016 Common Stock 20,323 (3) 20,323 D
Incentive Stock Option (Right to Buy) $14.38 09/16/2011 A 177 (2) 12/12/2016 Common Stock 177 (3) 177 D
Non Qualified Stock Option (Right to Buy) $15.95 09/16/2011 A 23,731 (2) 06/01/2017 Common Stock 23,731 (3) 23,731 D
Incentive Stock Option (Right to Buy) $15.95 09/16/2011 A 6,269 (2) 06/01/2017 Common Stock 6,269 (3) 6,269 D
Employee Stock Option (Right to Buy) $14.13 09/16/2011 A 15,000 (4) 11/05/2017 Common Stock 15,000 (3) 15,000 D
Employee Stock Option (Right to Buy) $12.29 09/16/2011 A 45,000 (5) 05/27/2018 Common Stock 45,000 (3) 45,000 D
Employee Stock Option (Right to Buy) $8.55 09/16/2011 A 65,000 (6) 05/26/2019 Common Stock 65,000 (3) 65,000 D
Restricted Stock Award $0 09/16/2011 A 4,250 (6) (6) Common Stock 4,250 (7) 4,250 D
Employee Stock Option (Right to Buy) $9.21 09/16/2011 A 40,000 (8) 11/18/2019 Common Stock 40,000 (3) 40,000 D
Restricted Stock Award $0 09/16/2011 A 15,000 (8) (8) Common Stock 15,000 (7) 15,000 D
Employee Stock Option (Right to Buy) $11.74 09/16/2011 A 115,800 (9) 05/17/2020 Common Stock 115,800 (3) 115,800 D
Restricted Stock Unit Award $0 09/16/2011 A 12,525 (9) (9) Common Stock 12,525 (7) 12,525 D
Employee Stock Option (Right to Buy) $18.105 09/16/2011 A 100,000 (10) 05/20/2021 Common Stock 100,000 (3) 100,000 D
Restricted Stock Unit Award $0 09/16/2011 A 15,000 (10) (10) Common Stock 15,000 (7) 15,000 D
Explanation of Responses:
1. Received in exchange for shares of Alkermes, Inc. common stock in connection with the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger"). On 9/16/11, the effective date of the Merger, the closing price of ALKS was $16.57 per share.
2. These options are fully vested in accordance with their terms.
3. Received in exchange for, and having substantially the same terms as, stock options of Alkermes, Inc. common stock in connection with the Merger.
4. 75% vested as of 9/16/11, remainder vests on 11/5/11.
5. 75% vested as of 9/16/11, remainder vests on 5/27/12.
6. 50% vested as of 9/16/11, remainder vests in 2 equal annual installments beginning on 5/26/12.
7. Received in exchange for, and having substantially the same terms as, restricted stock unit awards of Alkermes, Inc. common stock in connection with the Merger.
8. 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 11/18/11.
9. 25% vested as of 9/16/11, remainder vests in 3 equal annual installments beginning on 5/17/12.
10. Vests in 4 equal annual installments beginning on 5/20/12.
Remarks:
/s/ Jennifer Baptiste, attorney-in-fact for Elliot Ehrich 09/20/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.